Globe and Mail: Editorial supports MS clinical trials

Release Date: July 1, 2011 This content is archived.

Print

An editorial in the Globe and Mail about Canada's decision to participate in clinical trials of a potentially revolutionary treatment for multiple sclerosis notes a UB study casts doubt on the theory that vein blockages contribute to the disease, but the authors of that study also said, "It behooves the clinical research community to carefully pursue [the theory] to its end. We should neither jump on the bandwagon as it passes through town, nor assiduously miss the parade." An article in the Toronto Star also looks at UB's study.

Media Contact Information

John Della Contrada
Vice President for University Communications
521 Capen Hall
Buffalo, NY 14260
Tel: 716-645-4094 (mobile: 716-361-3006)
dellacon@buffalo.edu
Twitter: UBNewsSource